Measurement of C reactive protein concentration in myocardial ischemia and infarction

Abstract

 Myocardial ischemia and infarction represent significant health concerns. Inflammation plays a crucial role in the pathophysiology of these conditions. The elevation of CRP levels, an acute-phase protein, signifies the inflammatory status and has been associated with the severity and prognosis of myocardial damage. Measuring C-reactive protein (CRP) concentration in myocardial ischemia and infarction has garnered significant attention due to its potential role as a biomarker for cardiovascular risk stratification.